“…Multiple efforts to standardize data or advance the use of CDMs have been described in pediatric populations. Some examples include studies of children with multiple sclerosis, seizures, sickle cell disease, sleep‐disordered breathing, and rare kidney disease 16–19 . In some of these studies, the authors sought to ensure that systems could accurately identify children with certain conditions, 16,18 and in other studies, understanding treatment approaches for rare conditions was the goal 17 .…”